Risk and outcome in metastatic malignant melanoma patients receiving DTIC, cisplatin, BCNU and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha2a.

Combined chemo-/immunotherapy has shown high objective response rates and a significant though small proportion of long-term complete responders in metastatic malignant melanoma. The purpose of this study was to determine response rates, freedom from treatment failure (FFTF) and overall survival in...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Hoffmann, R., Müller, I., Neuber, K., Lassmann, S., Buer, J., Probst, M., Oevermann, K., Franzke, A., Kirchner, H., Ganser, A., Atzpodien, J.
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group|1 1998
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2063152/
https://ncbi.nlm.nih.gov/pubmed/9792153
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker